Bioventix Statistics
Total Valuation
Bioventix has a market cap or net worth of GBP 94.05 million. The enterprise value is 88.74 million.
| Market Cap | 94.05M |
| Enterprise Value | 88.74M |
Important Dates
The next estimated earnings date is Friday, June 26, 2026.
| Earnings Date | Jun 26, 2026 |
| Ex-Dividend Date | Apr 9, 2026 |
Share Statistics
Bioventix has 5.22 million shares outstanding. The number of shares has decreased by -0.08% in one year.
| Current Share Class | 5.22M |
| Shares Outstanding | 5.22M |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 6.15% |
| Owned by Institutions (%) | 69.45% |
| Float | 4.14M |
Valuation Ratios
The trailing PE ratio is 12.81.
| PE Ratio | 12.81 |
| Forward PE | n/a |
| PS Ratio | 7.50 |
| PB Ratio | 8.52 |
| P/TBV Ratio | 8.52 |
| P/FCF Ratio | 12.10 |
| P/OCF Ratio | 12.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.02, with an EV/FCF ratio of 11.42.
| EV / Earnings | 11.93 |
| EV / Sales | 7.08 |
| EV / EBITDA | 9.02 |
| EV / EBIT | 9.08 |
| EV / FCF | 11.42 |
Financial Position
The company has a current ratio of 6.12
| Current Ratio | 6.12 |
| Quick Ratio | 5.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 66.64% and return on invested capital (ROIC) is 127.96%.
| Return on Equity (ROE) | 66.64% |
| Return on Assets (ROA) | 46.91% |
| Return on Invested Capital (ROIC) | 127.96% |
| Return on Capital Employed (ROCE) | 88.52% |
| Weighted Average Cost of Capital (WACC) | 6.92% |
| Revenue Per Employee | 1.05M |
| Profits Per Employee | 619,761 |
| Employee Count | 12 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 1.48 |
Taxes
In the past 12 months, Bioventix has paid 2.46 million in taxes.
| Income Tax | 2.46M |
| Effective Tax Rate | 24.88% |
Stock Price Statistics
The stock price has decreased by -27.55% in the last 52 weeks. The beta is 0.48, so Bioventix's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -27.55% |
| 50-Day Moving Average | 1,604.60 |
| 200-Day Moving Average | 2,079.10 |
| Relative Strength Index (RSI) | 61.94 |
| Average Volume (20 Days) | 17,482 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioventix had revenue of GBP 12.54 million and earned 7.44 million in profits. Earnings per share was 1.41.
| Revenue | 12.54M |
| Gross Profit | 11.59M |
| Operating Income | 9.77M |
| Pretax Income | 9.90M |
| Net Income | 7.44M |
| EBITDA | 9.84M |
| EBIT | 9.77M |
| Earnings Per Share (EPS) | 1.41 |
Balance Sheet
The company has 5.30 million in cash and n/a in debt, with a net cash position of 5.30 million or 1.02 per share.
| Cash & Cash Equivalents | 5.30M |
| Total Debt | n/a |
| Net Cash | 5.30M |
| Net Cash Per Share | 1.02 |
| Equity (Book Value) | 11.04M |
| Book Value Per Share | 2.11 |
| Working Capital | 10.20M |
Cash Flow
In the last 12 months, operating cash flow was 7.80 million and capital expenditures -32,753, giving a free cash flow of 7.77 million.
| Operating Cash Flow | 7.80M |
| Capital Expenditures | -32,753 |
| Depreciation & Amortization | 65,275 |
| Net Borrowing | n/a |
| Free Cash Flow | 7.77M |
| FCF Per Share | 1.49 |
Margins
Gross margin is 92.45%, with operating and profit margins of 77.93% and 59.30%.
| Gross Margin | 92.45% |
| Operating Margin | 77.93% |
| Pretax Margin | 78.94% |
| Profit Margin | 59.30% |
| EBITDA Margin | 78.45% |
| EBIT Margin | 77.93% |
| FCF Margin | 61.95% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 8.22%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 8.22% |
| Dividend Growth (YoY) | -4.46% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 105.33% |
| Buyback Yield | 0.08% |
| Shareholder Yield | 8.30% |
| Earnings Yield | 7.91% |
| FCF Yield | 8.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bioventix has an Altman Z-Score of 45.78 and a Piotroski F-Score of 5.
| Altman Z-Score | 45.78 |
| Piotroski F-Score | 5 |